---
$id: https://graph.org.ai/products/commodity/51171935
$type: Product
source: UNSPSC
code: "51171935"
title: "Dexlansoprazole"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dexlansoprazole

**UNSPSC Code**: 51171935
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a proton pump inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UYE4T5I70X. European Medicines Agency schedules Dexlansoprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31929. Dexlansoprazole generally arises in the molecular formula C16H14F3N3O2S. The term DEXLANSOPRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 1, 2006, list 55.) DEXLANSOPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexlansoprazole under HS 29333999 and SITC 51574. As of Q4 2014, DEXLANSOPRAZOLE remains the US FDA Preferred Term for this commodity. Dexlansoprazole bears US NLM identifiers UMLS ID C2607263 and NCI Concept Code C73192. SMILES: CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F.

